D-0287-2021 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0287-2021 was initiated by Dr. Reddy's Laboratories, Inc. on Feb 17, 2021 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Dec 21, 2022). Affected quantity: a) 1350 bottles; b) 147 cartons.

Recall details

Product Type
Drugs
Report Date
Mar 3, 2021
Initiation Date
Feb 17, 2021
Termination Date
Dec 21, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 1350 bottles; b) 147 cartons

Product description

Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90); and b) For Institutional Use Only 30-count (3 x 10 unit-dose) tablets per carton (NDC 43598-344-31); Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540; Made in India.

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide in the USA

Code information

Lot #: a) H2000206, Exp 06/22; b) H2000138, Exp 06/22

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0287-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0287-2021. Report a data issue: hello@regdatalab.com.